1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Cancer Drug Shows Promise for Chronic Fatigue Syndrome – About – News & Issues

October 30, 2011Monoclonal Anti-CD20 Antibodiesadmin

Cancer Drug Shows Promise for Chronic Fatigue Syndrome
About - News & Issues
New research suggests that the cancer drug Rituxan (rituximab) may be an effective treatment for chronic fatigue syndrome. The findings also add support to the theory that chronic fatigue syndrome is ...
Chronic Fatigue Syndrome Treated by Cancer DrugAuthority Empire

all 4 news articles »

Post navigation

← Baby girl gets unselfish love from foster family, liver donor – Las Vegas Review – Journal Understanding of Pythons May Help in Treatment of Heart Failure – TestCountry.com (blog) →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos